Everolimus 0.75mg

Everolimus 0.75mg is a prescription medication widely used for its targeted action in treating various medical conditions, including certain cancers, organ transplant management, and specific non-cancerous tumors. Belonging to the mTOR inhibitor class, it works by disrupting pathways essential for cell growth and proliferation, effectively slowing disease progression and improving patient outcomes.

Everolimus 0.75mg Uses

Everolimus 0.75mg is employed in multiple therapeutic areas due to its versatile mechanism of action.

In cancer treatment, it is prescribed to manage advanced forms of cancers such as renal cell carcinoma, breast cancer, and certain neuroendocrine tumors. By inhibiting the mTOR pathway, it reduces cancer cell proliferation, slowing the growth and spread of tumors.

For organ transplantation, Everolimus 0.75mg is used to prevent organ rejection in patients undergoing kidney or liver transplants. It modulates the immune response, preventing the body from attacking the transplanted organ.

The drug is also used to treat benign tumors associated with tuberous sclerosis complex (TSC). It has shown efficacy in reducing the size of tumors in various organs, including the brain and kidneys.

Under the guidance of a healthcare provider, Everolimus 0.75mg can offer significant therapeutic benefits tailored to a patient’s condition.

Drug Interactions

Everolimus 0.75mg interacts with several medications, which may alter its efficacy or increase the risk of side effects.

Antifungal agents, such as ketoconazole, itraconazole, and voriconazole, can increase blood levels of Everolimus, raising the risk of toxicity. Similarly, certain antibiotics, including erythromycin and clarithromycin, can enhance its concentration, necessitating dose adjustments.

Antiepileptic drugs like carbamazepine, phenytoin, and phenobarbital may decrease the effectiveness of Everolimus by accelerating its breakdown in the body.

The concurrent use of immunosuppressants, such as cyclosporine or tacrolimus, may heighten the risk of infections or kidney-related side effects.

Blood-thinning medications like warfarin may increase the risk of bleeding when taken with Everolimus.

Patients must provide a complete list of medications, supplements, and herbal products to their healthcare provider to prevent harmful interactions.

Food Interactions

The absorption and efficacy of Everolimus 0.75mg can be influenced by dietary factors.

Grapefruit and grapefruit juice are known to inhibit enzymes responsible for breaking down Everolimus. This can result in elevated blood levels of the medication, potentially leading to increased side effects.

High-fat meals may delay the absorption of Everolimus. Although this may not significantly impact its overall effectiveness, taking the medication consistently with or without food ensures stable drug levels in the body.

While alcohol does not directly interact with Everolimus, excessive consumption may affect liver function, which is crucial for metabolizing the drug.

For best results, Everolimus should be taken at the same time each day, either on an empty stomach or following a consistent food pattern.

Contraindications

Everolimus 0.75mg is not suitable for everyone and is contraindicated in specific situations.

Patients with a known allergy to Everolimus or similar drugs, such as sirolimus or temsirolimus, should not take this medication. Severe allergic reactions may include rash, swelling, and difficulty breathing.

Individuals with severe liver impairment should avoid using Everolimus, as the drug’s metabolism may be significantly impaired, increasing the risk of adverse effects.

Pregnant and breastfeeding women should not use Everolimus due to the potential risks to the fetus or infant. Women of childbearing age should use effective contraception during treatment and for eight weeks after the final dose.

Patients with active infections should postpone starting Everolimus until the infection is treated, as the medication suppresses the immune system, making it harder for the body to fight infections.

Everolimus is contraindicated during the administration of live vaccines, as the suppressed immune response may result in vaccine-related complications.

Precautions and Warnings

Patients taking Everolimus 0.75mg must follow specific precautions to ensure safety and efficacy. The drug suppresses immune function, increasing susceptibility to infections. Patients should promptly report any signs of infection, such as fever, chills, or persistent cough, to their healthcare provider. Everolimus can cause non-infectious pneumonitis, a condition characterized by inflammation of the lungs. Symptoms include shortness of breath, coughing, and chest discomfort. Immediate medical attention is required if these symptoms occur. Kidney function may be affected, especially in transplant patients who are also taking cyclosporine. Regular kidney function tests are recommended to monitor for potential complications. The medication may delay wound healing. Patients undergoing surgery should inform their healthcare provider about their use of Everolimus.

Blood sugar levels may increase during treatment, particularly in diabetic patients. Regular monitoring of glucose levels is essential, and adjustments to diabetes medications may be necessary.

Storage

Proper storage of Everolimus 0.75mg is essential to maintain its effectiveness and safety. The medication should be stored at room temperature, ideally between 20°C and 25°C (68°F to 77°F). It must be kept away from direct sunlight, heat, and moisture, as these factors can degrade the drug. The tablets should remain in their original blister packaging until they are ready to be used to prevent exposure to air or humidity.

Keep Everolimus out of reach of children and pets to avoid accidental ingestion. Unused or expired tablets should not be flushed down the toilet or thrown in regular trash. Instead, follow local guidelines for proper disposal to prevent environmental contamination.